Eli Lilly to launch diabetes, obesity drug in India next year
NEW DELHI: Eli Lilly, the US pharmaceutical giant that gained widespread attention globally with its weight-loss treatments, plans to launch its blockbuster drug – Tirzepatide – in India in 2025.“India…